The FDA has taken action against 17 companies that are illegally selling unapproved and/or misbranded products that claim to prevent, treat, or cure Alzheimer disease and other serious diseases and health conditions.
Trazodone is not associated with a reduced risk for dementia compared with other antidepressants at the prodromal stage of disease.
In the United Kingdom, patients from minority ethnic groups have lower cognitive scores and are younger at first diagnosis of dementia than the white UK-born population.
Comprehensive dementia care programs may help more people stay in community-based settings and was cost neutral.
For older adults on the Alzheimer disease trajectory, women have elevated early tau deposition compared with men.
Aerobic exercise contributes to brain health in individuals as young as 20 years.
Currently, there are no approved therapies for the treatment of MSA, a rare progressive neurodegenerative disease.
Treating systolic blood pressure to a goal of less than 120 mm Hg rather than 140 mm Hg does not result in a significant reduction in the risk for probable dementia.
Crenezumab is an investigational monoclonal antibody that preferentially binds to and promotes the removal of neurotoxic oligomers, a form of beta-amyloid.
Algorithms that combine Internet of Things technologies and in-home sensory devices with machine learning techniques can be used to monitor the health and well-being of people with dementia.